Tozaro

Tozaro is revolutionizing the bioprocessing landscape by developing a novel suite of reagents designed to simplify and enhance the development and manufacture of viral vectors used in cell and gene therapy. The company operates in the biotechnology sector, specifically targeting the needs of pharmaceutical companies and research institutions involved in advanced therapeutic development. Tozaro's business model focuses on the production and sale of smart polymers and synthetic affinity reagents that streamline downstream processing, making it more intuitive and efficient. Revenue is generated through the sale of these specialized reagents and associated analytical devices, which are crucial for the accurate characterization and quantification of viral particles. The company also engages in technical support and consultancy services to ensure optimal application of their products.

Keywords: bioprocessing, viral vectors, cell therapy, gene therapy, smart polymers, synthetic reagents, downstream processing, biotechnology, pharmaceutical, analytical devices.